SEC FORM 3 SEC Form 3
FORM 3 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
 
OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response: 0.5
1. Name and Address of Reporting Person*
Tarangelo James J.

(Last) (First) (Middle)
C/O ARAMARK
1101 MARKET STREET

(Street)
PHILADELPHIA PA 19107

(City) (State) (Zip)
2. Date of Event Requiring Statement (Month/Day/Year)
11/01/2016
3. Issuer Name and Ticker or Trading Symbol
Aramark [ ARMK ]
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
X Officer (give title below) Other (specify below)
Vice President and Treasurer
5. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock 5,449.0989(1) D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year) 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (Right to Buy) (2) 06/05/2017 Common Stock 3,000 6.97 D
Stock Option (Right to Buy) (2) 06/03/2018 Common Stock 1,000 10.02 D
Stock Option (Right to Buy) (2) 06/24/2020 Common Stock 1,500 9.62 D
Stock Option (Right to Buy) (2) 12/07/2021 Common Stock 2,500 12.76 D
Stock Option (Right to Buy) (3) 02/07/2024 Common Stock 5,603 25.61 D
Stock Option (Right to Buy) (4) 11/19/2024 Common Stock 6,032 28.66 D
Stock Option (Right to Buy) (5) 11/20/2025 Common Stock 5,703 32.65 D
Explanation of Responses:
1. Includes 403.0613 restricted stock units which will vest in two annual installments on each of February 7, 2017 and 2018, 766.9494 performance stock units which will vest on February 7, 2017, 669.7082 restricted stock units which will vest in three annual installments on each of November 19, 2016, 2017 and 2018, 1,190.1381 performance stock units which will vest in two annual installments on each of November 19, 2016 and 2017 and 836.2419 restricted stock units which will vest in four annual installments on each of November 20, 2016, 2017, 2018 and 2019.
2. Represents stock options, all of which are fully vested.
3. Represents stock options, 2,800 of which have fully vested, 1,400 of which will vest on February 7, 2017 and 1,403 of which will vest on February 7, 2018.
4. Represents stock options, 1,508 of which have fully vested and 4,524 of which will vest in equal installments on November 19, 2016, 2017 and 2018.
5. These stock options vest in four equal annual installments on each of November 20, 2016, 2017, 2018 and 2019.
Remarks:
Exhibit Index: Exhibit 24 - Power of Attorney
/s/ Robert T. Rambo, as Attorney-in-fact 11/14/2016
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
Exhibit

James J. Tarangelo

POWER OF ATTORNEY


The undersigned hereby constitutes and appoints each of Harold B. Dichter, Robert T. Rambo, Jr., Arun Krishnan and Leticia Dorsa his true and lawful attorneys-in-fact to:

(1)    execute for and on behalf of the undersigned, in the undersigned’s capacity as a director or executive officer of Aramark (the “Company”), as applicable, (i) Forms 3, 4 or 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934, as amended, and the rules thereunder (including any amendments thereto) and (ii) such forms as may be required in connection with any applications for EDGAR access codes, including without limitation the Form ID.

(2)    do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete the execution of any such Form 3, 4, or 5 and the timely filing of such form with the United States Securities and Exchange Commission and any other authority; and

(3)    take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorneys-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorneys-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorneys-in-fact may approve in their discretion.

The undersigned hereby grants to such attorneys-in-fact full power and authority to do and perform every act and thing whatsoever requisite, necessary and proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorneys-in-fact, or their substitute or substitutes, shall lawfully do or cause to be done by virtue of this Power of Attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming any of the undersigned’s responsibilities to comply with Section 16 of the Securities Exchange Act of 1934, as amended.

This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4 and 5 with respect to the undersigned’s holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact.

IN WITNESS WHEREOF, the undersigned has executed this Power of Attorney on the 9th day of November, 2016.



/s/ JAMES J. TARANGELO
Signature


James J. Tarangelo
Printed Name


505496